Skip to content

Drug interactions

Asenapine transdermal + Lapatinib

Severity: Moderate

Asenapine transdermal and Lapatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can prolong the QTc interval, so combined use may raise the risk of torsades de pointes. Transdermal asenapine is not marketed in all regions, and its QT effect is expected to be smaller than with other forms.

What this interaction means in plain words

Asenapine transdermal and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive QT prolongation.

What to do

Obtain a baseline ECG and monitor QTc and electrolytes. Choose an antipsychotic with less QT effect if the patient has other risk factors.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Asenapine transdermal and Lapatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Asenapine transdermal with Lapatinib?

MediHelp rates the interaction as moderate. Asenapine transdermal and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can prolong the QTc interval, so combined use may raise the risk of torsades de pointes. Transdermal asenapine is not marketed in all regions, and its QT effect is expected to be smaller than with other forms.

How serious is the interaction between Asenapine transdermal and Lapatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor QTc and electrolytes. Choose an antipsychotic with less QT effect if the patient has other risk factors.

What other medicines interact with Lapatinib?

MediHelp also lists interactions of Lapatinib with, for example, Dofetilide, Ibutilide, Pimozide. The full list is on the Lapatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in